Mecomed and MedTech Europe, the European trade association for the medical technology industry, convened global and regional stakeholders at WHX Dubai—a premier global healthcare and MedTech platform—under the theme “The Power of MedTech: Driving Innovation Through Collaboration.”
The high-level MedTech policy and leadership exchange brought together international MedTech leaders, healthcare policymakers, regulatory authorities, industry executives, and trade associations to address the rapidly evolving global MedTech landscape. Discussions focused on regulatory harmonization, innovation frameworks, market access, and public–private collaboration to advance healthcare systems across emerging and mature markets.
Through expert panel discussions and executive dialogues, participants explored:
- The future outlook of the global medical devices and diagnostics industry
- The impact of EU MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) revisions on the Middle East and Africa region
- The growing role of artificial intelligence (AI) regulation in healthcare innovation
- Strategies for regulatory convergence and policy alignment between Europe and MEA markets
Speakers emphasized that regulatory modernization, cross-border collaboration, and knowledge exchange are essential to enabling safe, effective, and responsible medical innovation. Stronger alignment between international and regional frameworks can accelerate patient access to advanced medical technologies, digital health solutions, and life-saving diagnostics.
Industry Leadership Perspectives on MedTech Policy and Patient Access
“The MedTech sector is at a pivotal moment, and the policies we help shape today will determine how quickly patients can benefit from transformative technologies,” said Rami Rajab, Chief Executive Officer of Mecomed. “Our priority is ensuring that collaboration across the MedTech ecosystem translates into measurable impact for patients and sustainable healthcare systems throughout the Middle East and Africa.”
Diana Kanecka, Director of International Affairs at MedTech Europe, highlighted the importance of international regulatory cooperation: “Global collaboration is essential to ensure regulatory frameworks enable timely access to innovation. By working closely with regional partners such as Mecomed, we can promote best practices, strengthen regulatory alignment, and support policies that foster safe, responsible innovation while expanding patient access to medical technologies worldwide.”
Middle East & Africa Medical Devices Market Growth and Digital Health Transformation
As the Middle East and Africa region accelerates healthcare digital transformation and investment in advanced medical infrastructure, the regional medical devices market is projected to reach nearly USD 35 billion by 2032. This growth underscores the increasing importance of:
- Health technology assessment (HTA) reform
- Digital health and AI integration
- Regulatory capacity building
- Sustainable healthcare innovation ecosystems
Enhanced engagement between global MedTech associations, regulators, and industry stakeholders will be critical to ensuring innovation delivers tangible patient outcomes, improves healthcare accessibility, and strengthens health system resilience.
Ongoing Global–Regional Collaboration in the MedTech Sector
Building on the momentum of their joint session at WHX Dubai, Mecomed and MedTech Europe will continue expanding strategic cooperation through policy roundtables, capacity-building initiatives, leadership forums, and cross-regional knowledge exchange programs.
These efforts aim to support forward-looking regulatory frameworks, promote medical device innovation, enhance market access, and improve healthcare outcomes across Europe, the Middle East, and Africa.
